Cohort review of patients with parathyroid cancer in End Stage Renal Disease (ESRD).
Carcinoma
Hyperparathyroidism
Parathyroid
Parathyroidectomy
Renal
Journal
Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285
Informations de publication
Date de publication:
08 Oct 2024
08 Oct 2024
Historique:
received:
22
04
2024
accepted:
30
09
2024
medline:
8
10
2024
pubmed:
8
10
2024
entrez:
8
10
2024
Statut:
epublish
Résumé
Parathyroid carcinoma (PTTC) is a rare malignant endocrine tumor seen in up to 1-2% of all cases of primary hyperparathyroidism. However, incidence of parathyroid carcinoma in renal hyperparathyroidism is a rare phenomenon. We aimed to evaluate the outcomes of PTTC in renal hyperparathyroidism published in the literature. Cohort review of parathyroid cancer cases reported in Medline (via PubMed), COCHRANE and EMBASE between the period 1985 - 2023 in patients with renal hyperparathyroidism. A total of 48 patients (20 M: 28F), with a mean age of 49.8 (± 11.7 SD: range 20-75) years. Dialysis vintage was for a period of 8.9 (± 7.2; range 6 months to 40 years). The mean preoperative values were as follows: serum corrected calcium-2.87 IQR 2.56-3.01), PTH - 221.8 (IQR 86.6 -257.2 pmol/L) and serum phosphate - 2.07 (IQR 1.72-2.28) mmol/L. Preoperative imaging was in the form of ultrasound of the neck in 21 of 48 (44%), MIBI scan in 27/48 (56%), contrast enhanced computerized tomography in 14/48 (29%) and MRI neck in 1/48 (2%). The mean size of the cancer was 2.7 (± 1.35) cm and weight of the gland ranged between 0.9 to 4.98 g. 18/48 (37%) patients underwent a total parathyroidectomy and 30/48 (63%) had subtotal parathyroidectomy. En bloc excision of the tumour along with the thyroid along and central compartment lymph nodes was only performed in 12/48 (25%), of whom 9 (19%) had it performed at index surgery, whereas in the rest was done for persistent or recurrent disease. After a mean follow up of 34 months, 14 (29%) had local recurrence, 1 (2%) had distant metastasis to the skeletal system, and 12 (25%) to the lungs. Cohort mortality was 6 (13%) due to refractory hypercalcemia. Parathyroid carcinoma in renal hyperparathyroidism is rare but when encountered, en bloc excision with parathyroidectomy provides the best chance of cure. Recurrences can be difficult to treat but may be needed to treat intractable hypercalcaemia.
Sections du résumé
BACKGROUND AND HYPOTHESIS
OBJECTIVE
Parathyroid carcinoma (PTTC) is a rare malignant endocrine tumor seen in up to 1-2% of all cases of primary hyperparathyroidism. However, incidence of parathyroid carcinoma in renal hyperparathyroidism is a rare phenomenon. We aimed to evaluate the outcomes of PTTC in renal hyperparathyroidism published in the literature.
METHODS
METHODS
Cohort review of parathyroid cancer cases reported in Medline (via PubMed), COCHRANE and EMBASE between the period 1985 - 2023 in patients with renal hyperparathyroidism.
RESULTS
RESULTS
A total of 48 patients (20 M: 28F), with a mean age of 49.8 (± 11.7 SD: range 20-75) years. Dialysis vintage was for a period of 8.9 (± 7.2; range 6 months to 40 years). The mean preoperative values were as follows: serum corrected calcium-2.87 IQR 2.56-3.01), PTH - 221.8 (IQR 86.6 -257.2 pmol/L) and serum phosphate - 2.07 (IQR 1.72-2.28) mmol/L. Preoperative imaging was in the form of ultrasound of the neck in 21 of 48 (44%), MIBI scan in 27/48 (56%), contrast enhanced computerized tomography in 14/48 (29%) and MRI neck in 1/48 (2%). The mean size of the cancer was 2.7 (± 1.35) cm and weight of the gland ranged between 0.9 to 4.98 g. 18/48 (37%) patients underwent a total parathyroidectomy and 30/48 (63%) had subtotal parathyroidectomy. En bloc excision of the tumour along with the thyroid along and central compartment lymph nodes was only performed in 12/48 (25%), of whom 9 (19%) had it performed at index surgery, whereas in the rest was done for persistent or recurrent disease. After a mean follow up of 34 months, 14 (29%) had local recurrence, 1 (2%) had distant metastasis to the skeletal system, and 12 (25%) to the lungs. Cohort mortality was 6 (13%) due to refractory hypercalcemia.
CONCLUSIONS
CONCLUSIONS
Parathyroid carcinoma in renal hyperparathyroidism is rare but when encountered, en bloc excision with parathyroidectomy provides the best chance of cure. Recurrences can be difficult to treat but may be needed to treat intractable hypercalcaemia.
Identifiants
pubmed: 39377972
doi: 10.1007/s00423-024-03496-5
pii: 10.1007/s00423-024-03496-5
doi:
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
300Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Lee PK, Jarosek SL, Virnig BA et al (2007) Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 109(9):1736–1741
pubmed: 17372919
doi: 10.1002/cncr.22599
Hundahl SA, Fleming ID, Fremgen AM et al (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985–1995: a national cancer data base report. The American college of surgeons commission on cancer and the American cancer society. Cancer 86(3):538–544
pubmed: 10430265
doi: 10.1002/(SICI)1097-0142(19990801)86:3<538::AID-CNCR25>3.0.CO;2-K
Favia G, Lumachi F, Polistina F et al (1998) Parathyroid carcinoma: sixteen new cases and suggestions for correct management. World J Surg 22(12):1225–1230
pubmed: 9841748
doi: 10.1007/s002689900549
Berland Y, Olmer M, Lebreuil G et al (1982) Parathyroid carcinoma, adenoma and hyperplasia in a case of chronic renal insufficiency on dialysis. Clin Nephrol 18(3):154–158
pubmed: 7140028
Tang JA, Friedman J, Hwang MS et al (2017) Parathyroidectomy for tertiary hyperparathyroidism: a systematic review. Am J Otolaryngol 38(5):630–635
pubmed: 28735762
doi: 10.1016/j.amjoto.2017.06.009
Cappellacci F, Medas F, Canu GL et al (2020) Parathyroid carcinoma in the setting of tertiary hyperparathyroidism: case report and review of the literature. Case Rep Endocrinol 2020:5710468
pubmed: 33343947
pmcid: 7725582
Sherlock DJ, Newman J, Holl-Allen RT (1985) Parathyroid carcinoma presenting as tertiary hyperparathyroidism. Postgrad Med J 61(713):243–244
pubmed: 3983057
pmcid: 2418190
doi: 10.1136/pgmj.61.713.243
Ireland JP, Fleming SJ, Levison DA et al (1985) Parathyroid carcinoma associated with chronic renal failure and previous radiotherapy to the neck. J Clin Pathol 38(10):1114–1118
pubmed: 4056066
pmcid: 499451
doi: 10.1136/jcp.38.10.1114
Krishna GG, Mendez M, Levy B et al (1989) Parathyroid carcinoma in a chronic hemodialysis patient. Nephron 52(2):194–195
pubmed: 2739858
doi: 10.1159/000185635
Kodama M, Ikegami M, Imanishi M et al (1989) Parathyroid carcinoma in a case of chronic renal failure on dialysis. Urol Int 44(2):110–112
pubmed: 2728122
doi: 10.1159/000281482
Greenberg A, Piraino BM, Bruns FJ (1989) Hypercalcemia in patients with advanced chronic renal failure not yet requiring dialysis. Am J Nephrol 9(3):205–210
pubmed: 2757079
doi: 10.1159/000167966
Rademaker P, Meijer S, Oosterhuis JW et al (1990) Successful surgical treatment of parathyroid carcinoma in two haemodialysis patients. Nephrol Dial Transplant 5(7):545–548
pubmed: 2130303
doi: 10.1093/ndt/5.7.545
Iwamoto N, Yamazaki S, Fukuda T et al (1990) Two cases of parathyroid carcinoma in patients on long-term hemodialysis. Nephron 55(4):429–431
pubmed: 2392196
doi: 10.1159/000186013
Tominaga Y, Numano M, Uchida K et al (1995) Lung metastasis from parathyroid carcinoma causing recurrent renal hyperparathyroidism in a hemodialysis patient: report of a case. Surg Today 25(11):984–986
pubmed: 8640028
doi: 10.1007/BF00312388
Miki H, Sumitomo M, Inoue H et al (1996) Parathyroid carcinoma in patients with chronic renal failure on maintenance hemodialysis. Surgery 120(5):897–901
pubmed: 8909528
doi: 10.1016/S0039-6060(96)80101-2
Dionisio P, Stramignoni E, Passarino G et al (1996) Recurrent secondary hyperparathyroidism due to parathyroid carcinoma: usefulness of Ki-67 immunostaining in the diagnosis of a malignant parathyroid tumor. Nephron 74(4):720–723
pubmed: 8956308
doi: 10.1159/000189481
Tseng CC, Huang JJ, Wang MC et al (1999) Parathyroid carcinoma with multiple lung metastases. Nephrol Dial Transplant 14(2):449–451
pubmed: 10069211
doi: 10.1093/ndt/14.2.449
Takami H, Kameyama K, Nagakubo I (1999) Parathyroid carcinoma in a patient receiving long-term hemodialysis. Surgery 125(2):239–240
pubmed: 10026762
doi: 10.1016/S0039-6060(99)70273-4
Jayawardene S, Owen WJ, Goldsmith DJ (2000) Parathyroid carcinoma in a dialysis patient. Am J Kidney Dis 36(4):E26
pubmed: 11007701
doi: 10.1053/ajkd.2000.17733
Zivaljevic V, Krgovic K, Tatic S et al (2002) Parathyroid cancer in a hemodialysis patient: a case report. Tumori 88(5):430–432
pubmed: 12487567
doi: 10.1177/030089160208800518
Srouji IA, Resouly A, Cree IA (2004) Case of thymic parathyroid carcinoma in a haemodialysis patient: application of tumour chemosensitivity testing. J Laryngol Otol 118(2):162–164
pubmed: 14979960
doi: 10.1258/002221504772784685
Khan MW, Worcester EM, Straus FH 2nd et al (2004) Parathyroid carcinoma in secondary and tertiary hyperparathyroidism. J Am Coll Surg 199(2):312–319
pubmed: 15275889
doi: 10.1016/j.jamcollsurg.2004.04.014
Pineda E, Perez-Ordonez B, Dackiw A et al (2005) Parathyroid carcinoma should be suspected in dialysis patients with rapid changes in serum parathormone levels. Perit Dial Int 25(1):93–94
pubmed: 15770934
doi: 10.1177/089686080502500119
Obregón LM, Taylor MF, Mir G et al (2005) Parathyroidectomy for parathyroid carcinoma in renal transplantation. Transplant Proc 37(2):973–976
pubmed: 15848595
doi: 10.1016/j.transproceed.2004.12.305
Bossola M, Tazza L, Ferrante A et al (2005) Parathyroid carcinoma in a chronic hemodialysis patient: case report and review of the literature. Tumori 91(6):558–562
pubmed: 16457158
doi: 10.1177/030089160509100619
Tominaga Y, Tsuzuki T, Matsuoka S et al (2008) Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease. World J Surg 32(5):815–821
pubmed: 18338208
doi: 10.1007/s00268-007-9458-8
Nasrallah MP, Fraker DL, LiVolsi VA (2014) Parathyroid carcinoma in the setting of tertiaryhyperparathyroidism after renal transplant. Endocr Pathol 25(4):433–435
pubmed: 25284121
doi: 10.1007/s12022-013-9278-3
Kim BS, Ryu HS, Kang KH et al (2016) Parathyroid carcinoma in tertiary hyperparathyroidism. Asian J Surg 39(4):255–259
pubmed: 27664600
doi: 10.1016/j.asjsur.2013.01.007
Takada D, Tsukamoto T, Fuse M et al (2017) The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: a case report. BMC Nephrol 18(1):315
pubmed: 29047366
pmcid: 5648519
doi: 10.1186/s12882-017-0733-0
Pappa A, Hackman T (2017) Simultaneous incidental parathyroid carcinoma and intrathyroid parathyroid gland in suspected renal failure induced hyperparathyroidism. Surg J (N Y) 3(1):e23–e24
pubmed: 28825015
doi: 10.1055/s-0037-1599072
Won HR, Kang JY, Lee IH et al (2019) Parathyroid carcinoma arising from auto-transplanted parathyroid tissue after Total Parathyroidectomy in chronic kidney disease patient: a case report. BMC Nephrol 20(1):414
pubmed: 31730449
pmcid: 6858716
doi: 10.1186/s12882-019-1606-5
Kim MK, Song CM, Tae K et al (2019) Intrathyroidal parathyroid carcinoma in chronic kidney disease: a case report and review of literature. 대한이비인후과학회지 두경부외과학 62(12):740
Shen Y, Fei P (2019) Refractory hypercalcemia due to an ectopic mediastinal parathyroid gland in a hemodialysis patient: a case report. BMC Nephrol 20(1):165
pubmed: 31088386
pmcid: 6518768
doi: 10.1186/s12882-019-1363-5
Curto LS, Gervasi R, Caracciolo F et al (2019) Parathyroid carcinoma presenting with chronic renal failure and single pulmonary metastasis: A case report. Int J Surg Case Rep 65:322–324
pubmed: 31770707
pmcid: 6879974
doi: 10.1016/j.ijscr.2019.10.086
Malipedda S, Kamaleshwaran KK, Muthusamy D et al (2020) Rare Imaging Findings of Concomitant Presence of Multiple Parathyroid Adenomas and Carcinoma in a Chronic Kidney Disease Patient with Tertiary Hyperparathyroidism Detected on (99m)Tc-Sestamibi Single-Photon-Emission Computed Tomography/Computed Tomography Scintigraphy. Indian J Nucl Med 35(4):333–335
pubmed: 33642760
pmcid: 7905269
doi: 10.4103/ijnm.IJNM_100_20
Bouatay RHK, Njima M, Koubaa J (2020) Parathyroid carcinoma and secondary hyperparathyroidism: a case report. J Case Rep Clin Images 3(1):1038
Kada S, Tanaka M, Yasoda A (2021) Parathyroid carcinoma in a patient with secondary hyperparathyroidism and thyroid hemiagenesis: a case report and review of the literature. Ear, Nose Throat J 103(1):NP25-NP30
Sawab Al Hosni. YAB, Shebl A (2022) Parathyroid Carcinoma in a Young Patient with End-Stage Renal Disease: a Case Report from Oman. J Clin Surg Res 3(5):1–4
Zivaljevic V, Zivic R, Slijepcevic N et al (2023) Parathyroid carcinoma in chronic renal disease - a case series of three patients and review of literature. Acta Chir Belg 123(2):199–206
pubmed: 34459368
doi: 10.1080/00015458.2021.1970438
Yokoyama K, Suganuma N, Rino Y (2023) Left parathyroid carcinoma with secondary hyperparathyroidism: a case report. BMC Endocr Disord 23(1):108
pubmed: 37193977
pmcid: 10186659
doi: 10.1186/s12902-023-01370-x
Radu P, Garofil D, Tigora A et al (2023) Parathyroid cancer-a rare finding during parathyroidectomy in high volume surgery centre. Medicina (Kaunas) 59(3):448
pubmed: 36984449
doi: 10.3390/medicina59030448
Krupinova J, Kim E, Eremkina A et al (2023) Multiple metastases of parathyroid and papillary thyroid carcinoma in a female patient treated with long-term hemodialysis. J Pers Med 13(3):548
pubmed: 36983729
pmcid: 10053015
doi: 10.3390/jpm13030548
Zheng VM, Fei Leong EK, Pinto D et al (2024) A Case of Parathyroid Carcinoma in Renal Hyperparathyroidism. Case Rep Oncol 17(1):283–290
pubmed: 38371168
pmcid: 10870123
doi: 10.1159/000536444
Tominaga Y, Numano M, Takagi H et al (1995) Lung metastasis from parathyroid carcinoma causing recurrent renal hyperparathyroidism in a hemodialysis patient : report of a case. Surg Today (Tokyo, Japan) 25(11):984–986
doi: 10.1007/BF00312388
Tominaga Y, Takagi H (1996) Molecular genetics of hyperparathyroid disease. Curr Opin Nephrol Hypertens 5(4):336–341
pubmed: 8823531
doi: 10.1097/00041552-199607000-00008
Howell VM, Haven CJ, Kahnoski K et al (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40(9):657–663
pubmed: 12960210
pmcid: 1735580
doi: 10.1136/jmg.40.9.657
Shattuck TM, Välimäki S, Obara T et al (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349(18):1722–1729
pubmed: 14585940
doi: 10.1056/NEJMoa031237
Tan M-H, Morrison C, Soo KC et al (2004) Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 10(19):6629–6637
pubmed: 15475453
doi: 10.1158/1078-0432.CCR-04-0493
Erickson LA, Mete O, Juhlin CC et al (2022) Overview of the 2022 WHO classification of parathyroid tumors. Endocr Pathol 33(1):64–89
pubmed: 35175514
doi: 10.1007/s12022-022-09709-1
Schulte K-M, Talat N (2012) Diagnosis and management of parathyroid cancer. Nat Rev Endocrinol 8(10):612–622
pubmed: 22751344
doi: 10.1038/nrendo.2012.102
Busaidy NL, Jimenez C, Habra MA et al (2004) Parathyroid carcinoma: a 22-year experience. Head Neck 26(8):716–726
pubmed: 15287039
doi: 10.1002/hed.20049
Sandelin K, Auer G, Bondeson L et al (1992) Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg 16(4):724–731
pubmed: 1413841
doi: 10.1007/BF02067369
Iacobone M, Ruffolo C, Lumachi F et al (2005) Results of iterative surgery for persistent and recurrent parathyroid carcinoma. Langenbecks Arch Surg 390(5):385–390
pubmed: 15933877
doi: 10.1007/s00423-005-0555-6
Iacobone M, Lumachi F, Favia G (2004) Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases. J Surg Oncol 88(4):223–228
pubmed: 15565599
doi: 10.1002/jso.20152
Tsai W-H, Zeng Y-H, Lee C-C et al (2022) Mortality factors in recurrent parathyroid cancer: a pooled analysis. J Bone Miner Metab 40(3):508–517
pubmed: 35184206
doi: 10.1007/s00774-021-01305-3
Schulte K-M, Talat N, Galatá G (2022) Margin free resection achieves excellent long term outcomes in parathyroid cancer. Cancers 15(1):199
pubmed: 36612195
pmcid: 9818355
doi: 10.3390/cancers15010199
Asare EA, Sturgeon C, Winchester DJ et al (2015) Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the national cancer data base (NCDB). Ann Surg Oncol 22(12):3990–3995
pubmed: 26077914
doi: 10.1245/s10434-015-4672-3
Sadler C, Gow KW, Beierle EA et al (2014) Parathyroid carcinoma in more than 1,000 patients: A population-level analysis. Surgery 156(6):1622–1629; discussion 1629–1630